PC
GNMK

Polar Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Polar Capital’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$158K Buy
+11,100
New +$170K ﹤0.01% 297

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Polar Capital's GNMK Position: Q3 2020 in Review

Polar Capital opened a new position in GenMark Diagnostics, Inc (GNMK) in Q3 2020: 11,100 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #297 among its holdings.

163 funds tracked by Wall St. Rank hold GNMK as of Q3 2020.

  • Polar Capital held 11,100 shares of GenMark Diagnostics, Inc worth $158K as of Q3 2020.
  • GenMark Diagnostics, Inc was a new Polar Capital position in Q3 2020.
  • GenMark Diagnostics, Inc made up ﹤0.01% of Polar Capital's portfolio in Q3 2020, its #297 holding.
  • 163 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.